Risk Management Solutions have released a few more details about their role in the recent Swiss Re mortality transaction Vita Capital IV Ltd. The transaction gives Swiss Re more coverage to allow for any increased mortality which results from H1N1 swine flu. It’s the first deal of its kind being a mortality transaction which uses […]
Read the full article
Swiss Re have now completed their latest life insurance securitization, Vita Capital IV Ltd. The mortality bond transaction provides Swiss Re with $75m of cover against severe population mortality in the U.S. or the UK. The deal covers a five-year risk period ending in 2014. The notes issued by Vita Capital have been rated ‘BB+’ […]
Read the full article
The catastrophe bond market issuers and investors will all be keeping a watchful eye on the development of the swine flu outbreak with some nervousness. Why you might wonder, given that the vast majority of our coverage of the catastrophe bond market relates to natural disasters such as windstorms and earthquakes? Well, there is another […]
Read the full article
